Nigel McCracken
Geschäftsführer bei VIRAX BIOLABS GROUP LIMITED
Aktive Positionen von Nigel McCracken
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VIRAX BIOLABS GROUP LIMITED | Geschäftsführer | 01.09.2023 | - |
Karriereverlauf von Nigel McCracken
Ehemalige bekannte Positionen von Nigel McCracken
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BERGENBIO ASA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 | 01.09.2023 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | 01.09.2014 | 01.04.2019 |
| Corporate Officer/Principal | 01.09.2014 | 01.04.2019 | |
| NUCANA PLC | Geschäftsführer | - | - |
Ausbildung von Nigel McCracken
| University of Strathclyde | Undergraduate Degree |
| King's College London | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
| Schweiz | 2 |
| Norwegen | 2 |
Operativ
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BERGENBIO ASA | Health Technology |
| NUCANA PLC | Health Technology |
| VIRAX BIOLABS GROUP LIMITED | Finance |
| Private Unternehmen | 1 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Börse
- Insiders
- Nigel McCracken
- Erfahrung
